Lecture - London, United Kingdom
The Royal Society GlaxoSmithKline Prize and Lecture is awarded biennially for original contributions to medical and veterinary sciences. Dr Nicholas Lydon FRS was awarded the 2014 Royal Society GlaxoSmithKline Prize and Lecture for the development of the drug imatinib, a targeted tyrosine kinase inhibitor that has transformed the treatment of chronic myelogenous leukaemia (CML) and is a paradigm for cancer drug discovery.
Speakers: Dr Nicholas Lydon FRS, Granite Biopharma LLC
Organization: The Royal Society
Tuesday, 23 September 2014 (6:30 pm - 7:30 pm)
The Royal Society
6-9 Carlton House Terrace, London, United Kingdom
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
